Morphine and propranolol co-administration impair consolidation of Y-maze spatial recognition memory

Jie Zhang1, Jing He, Yan Mei Chen

  • 1Laboratory of Primate Neuroscience Research and Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, 650223, PR China.

Brain Research
|July 16, 2008
PubMed

Insights

Morphine and propranolol together disrupt spatial memory consolidation in mice. This suggests the beta-adrenergic system is involved in morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Opioid analgesics like morphine can impact cognitive functions.
  • Beta-adrenergic receptors play a role in memory processes.
  • Understanding drug interactions is crucial for cognitive health.

Purpose of the Study:

  • To investigate the combined effects of morphine and propranolol on memory consolidation.
  • To explore the role of the beta-adrenergic system in morphine's effects on memory.

Main Methods:

  • A two-trial recognition Y-maze task was used in mice.
  • Drugs were administered post-training with varying inter-trial intervals (2 and 4 hours).
  • Locomotor activity was monitored to control for confounding effects.

Main Results:

  • Neither morphine nor propranolol alone impaired memory consolidation.
  • Co-administration of morphine and propranolol significantly disrupted memory consolidation.
  • Higher doses of both drugs resulted in greater memory impairment.

Conclusions:

  • Morphine and propranolol co-administration negatively impacts spatial recognition memory consolidation.
  • Inactivation of the beta-adrenergic system may underlie morphine-induced memory deficits.
  • This interaction highlights the complex interplay between opioid and adrenergic systems in memory.

Related Concept Videos

Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...